Home > Insider Trading > Filing (0001644348-15-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159036	Halozyme Therapeutics Inc	HALO	Biological Products, (No Disgnostic Substances) (2836)	880488686

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1644348	Laurie Stelzer	11388 Sorrento Valley Road San Diego CA 92121	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-20	10,000	$17.24	10,000	No	4	P	Indirect	By trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By trust

Footnotes

This amendment is being filed to correct a typographical error contained in footnote (1) of the original filing. Although the transaction was correctly reported in Table I, the footnote incorrectly indicated that shares were sold in multiple transactions. The footnote should correctly read as follows: The price reported is the average weighted price. The shares were purchased in multiple transactions at prices ranging from $17.21 to $17.25, inclusive. The reporting person undertakes to provide to the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were purchased.Pursuant to previous SEC staff guidance, the previously reported transaction in Table I of the original filing is included in this amendment solely to permit this amendment to be filed.
The reporting person is co-trustee of The Gregory and Laureen Stelzer Living Trust.